Orgenesis Inc. EBT margin

EBT margin of ORGS for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBT margin growth rates and interactive chart. The Earnings before tax margin. Calculated as earnings before tax divided by revenue. Measures the profitability of a company after all expenses are paid but before taxes. This is useful to compare various companies in an industry that might have different tax regimes or tax rates.

Highlights and Quick Summary

  • EBT margin for the quarter ending September 29, 2021 was -116.23% (a 349.81% increase compared to previous quarter)
  • Year-over-year quarterly EBT margin decreased by -94.96%
  • Annual EBT margin for 2020 was -1264.19% (a 116.02% increase from previous year)
  • Annual EBT margin for 2019 was -585.23% (a 514.48% increase from previous year)
  • Annual EBT margin for 2018 was -95.24% (a -0.0% decrease from previous year)
  • Twelve month EBT margin ending September 29, 2021 was -213.41% (a -21.89% decrease compared to previous quarter)
  • Twelve month trailing EBT margin decreased by -83.12% year-over-year
Trailing EBT margin for the last four month:
29 Sep '21 29 Jun '21 30 Mar '21 30 Dec '20
-213.41% -273.2% -592.5% -1264.19%
Visit for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBT margin of Orgenesis Inc.

Most recent EBT marginof ORGS including historical data for past 10 years.

Interactive Chart of EBT margin of Orgenesis Inc.

Orgenesis Inc. EBT margin for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 -116.23% -25.84% -1.78%
2020 -2307.53% -554.31% -1549.97% -376.04% -1264.19%
2019 -476.1% -343.26% -432.54% -1999.76% -585.23%
2018 -133.45% -30.77% -69.05% -222.8% -95.24%
2017 -137.35% -127.68% 0.0% -302.92% -135.56%
2016 0.0% -163.12% 0.0% -399.82% -399.82% -197.91%
2015 -180.26%
2014 0.0%
2013 0.0%
2012 0.0%
2011 0.0%

Business Profile of Orgenesis Inc.

Sector: Healthcare
Industry: Biotechnology
Orgenesis Inc., a biotech company, focusing on cell and gene therapies (CGTs). The company develops a Point of Care (POCare) platform includes three enabling components: a pipeline of licensed POCare Therapeutics that are processed and produced in closed, automated POCare Technology systems across a collaborative POCare Network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company's POCare Network brings together patients, doctors, industry partners, research institutes, and hospitals for the clinical development and production of therapies worldwide. Orgenesis Inc. has a collaboration agreement with Savicell Diagnostics Ltd. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.